First-Pass Metabolism of ONO-5046 (N-[2-[4-(2,2-Dimethylpropionyloxy)phenylsulfonylamino]benzoyl]-aminoacetic Acid), a Novel Elastase Inhibitor, in Rats

スポンサーリンク

概要

• 論文の詳細を見る

• The first-pass metabolism in the intestine and liver of ONO-5046 (N-[2-[4-(2,2-dimethylpropionyloxy)phenylsulfonylamino]benzoyl]aminoacetic acid), a newly synthesized elastate inhibitor, was separately estimated in rats. When ONO-5046 solution was administered into the whole intestine via the bile duct at a dose of 5 μmol/rat, the extent of bioavailability was only 1.5%. A small but significant increase in the bioavailability with an increase in the dose suggested marked first-pass metabolism with a saturable process. Hepatic first-pass metabolism was estimated by determining the hepatic extraction ratio of ONO-5046 after administration into the portal vein at two different infusion rates (5 μmol/kg/9 min or 5 μmol/kg/20 s). The extraction ratio was relatively small and constant (about 20%) under 2 different infusion rates of the drug. Intestinal first-pass metabolism was estimated by determining the drug recovery in the measenteric plasma after administering the drug into the intestinal loop in situ (mesenteric blood collecting method in situ). The recovery percentage of ONO-5046 in the mesenteric plasma was small (2.58±0.04% at a dose of 1 μmol/rat), and the remaining ONO-5046 recovered in the mesenteric plasma and in the intestinal loop was a metabolite of ONO-5046 (EI-601,N-[2-[(4-hydroxyphenyl)sulfonylamino]benzoyl]aminoacetic acid). Recovery percentage of ONO-5046 in the mesenteric plasma increased significantly with an increase in the dose, although the recovery percentage was still low, even at a higher dose (9.55±1.17% of dose at a dose of 5 μmol/rat). These results indicate that the low oral bioavailability of ONO-5046 in vivo is mainly due to the marked intestinal first-pass metabolism, including the metabolism in the intestinal fluid, and the dose-dependent oral bioavailability was derived from the saturable intestinal first-pass metabolism.

• 公益社団法人日本薬学会の論文
• 1997-04-15

著者

• Higashi Y

  Institute Of Pharmaceutical Sciences Hiroshima University School Of Medicine

• Higashi Yutaka

  Institute Of Pharmaceutical Sciences Hiroshima University School Of Medicine

• Murakami T

  Institute Of Pharmaceutical Sciences Hiroshima University School Of Medicine

• Murakami Teruo

  Research And Development Center Toshiba Corporation

• Higashi Yutaka

  Department Of Pharmaceutics Institute Of Pharmaceutical Sciences Hiroshima University School Of Medi

• Yata Noburu

  Faculty Of Pharmaceutical Sciences Fukuyama University:department Of Pharmaceutics Institute Of Phar

• Murakami Teruo

  Institute Of Pharmaceutical Sciences Hiroshima University School Of Medicine

• Murakami T

  Hiroshima Univ. School Of Medicine Hiroshima Jpn

• YATA Noboru

  Institute of Pharmaceutical Sciences, Hiroshima University School of Medicine

• Yata Noboru

  Institute Of Pharmaceutical Sciences Hiroshima University School Of Medicine:faculty Of Pharmaceutic

• Yata Noboru

  Institute Of Pharmaceutical Sciences Hiroshima University

• Kato A

  National Inst. Infectious Diseases Tokyo Jpn

• WATANABE Fumiko

  Institute of Pharmaceutical Sciences, Hiroshima University School of Medicine

• SATO Masahiko

  Institute of Pharmaceutical Sciences, Hiroshima University School of Medicine

• KATO Akiko

  Institute of Pharmaceutical Sciences, Hiroshima University School of Medicine

• Watanabe F

  Nara‐women's Univ. Nara Jpn

• Sato Masahiko

  Institute Of Pharmaceutical Sciences Hiroshima University School Of Medicine

• KATO Akiko

  Institute for Laboratory Animals, Niigata University School of Medicine

関連論文

• A POSSIBLE MECHANISM OF ABSORPTION PROMOTERS
• ROLE OF ACIDIC PHOSPHOLIPIDS IN TISSUE DISTRIBUTION OF QUINIDINE IN RATS
• Study on Brain Uptake of Local Anesthetics in Rats
• First-Pass Metabolism of ONO-5046 (N-[2-[4-(2,2-Dimethylpropionyloxy)phenylsulfonylamino]benzoyl]-aminoacetic Acid), a Novel Elastase Inhibitor, in Rats
• Response of A431 Experimental Human Solid Xenograft to Mitomycin C in Combination with Human Epidermal Growth Factor in Mice
• ENHANCED RECTAL ABSORPTION OF β-LACTAM ANTIBIOTICS IN RAT BY MONODESMOSIDES ISOLATED FROM PERICARPS OF SAPINDUS MUKUROSSI (ENMEI-HI)
• EFFECT OF ANESTHESIA ON DRUG DISPOSITION IN THE RAT
• Brain and Cerebrospinal Fluid Distributions of Metoprolol in Rats
• ANTI-TUMOR ACTIVITY OF 1-ACETYL-3-o-TOLUYL-5-FLUOROURACIL AGAINST MURINE HEPATOMA MH134 AND ITS EFFECTS ON TISSUE WEIGHTS FOLLOWING SUBCUTANEOUS AND ORAL ADMINISTRATION
• Distribution of Quinidine in Rats with Carbon Tetrachloride-Intoxicated Hepatic Disease
• Dose-Dependent Pharmacokinetics and First-Pass Metabolism of Acetaminophen in Rats
• A POSSIBLE CONTRIBUTION OF PHOSPHOLIPIDS IN TISSUE DISTRIBUTION OF QUINIDINE IN RATS
• Effect of Some Amino Acids on the Rectal Irritation Caused by Sodium Caprate in Conscious Rats
• HEPATO-BILIARY TRANSPORT OF AMARANTH BY SINGLE PASS LIVER PERFUSION IN NORMAL AND CARBON TETRACHLORIDE OR α-NAPHTHYLISOTHIOCYANATE TREATED RATS
• High-Density and High-Carrier-to-Noise-Ratio Optical Disk Mastering : High Density Recording
• High-Density and High-Carrier-to-Noise-Ratio Optical Disk Mastering
• Evaluation of Adoptive Immunotherapy for Ehrlich Tumors in Mice
• Susceptibility of H-2 and Ly Congenic Mice to Ehrlich Ascites Tumors
• Effect of Polyol Fatty Acid Esters on Diclofenac Permeation through Rat Skin
• The Efficiency of Adoptive Immunotherapy for Ehrlich Tumors in Miceand Fate of the Transferred Spleen Cells in the Recipient
• In Vitro Evaluation of Nasal Mucociliary Clearance Using Excised Rat Nasal Septum
• In Vitro Evaluation of the Ciliary Beat Frequency of the Rat Nasal Epithelium Using a High-Speed Digital Imaging System
• Influence of Phospholipid and Protein Constituents on Tribological Properties of Artificial Hydrogel Cartilage Material
• The First Record of Teuchophorus ussurianus (Diptera, Dolichopodidae) from Japan

もっと見る 閉じる

スポンサーリンク